Michael J. McElhaugh

Insider Reports History

Entity
Individual
Location
C/O Oncore Biopharma, Inc., 3805 Old Easton Road, Doylestown, PA
Signature
/s/ David C. Hastings as attorney-in-fact for Michael J. McElhaugh
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael J. McElhaugh:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Arbutus Biopharma Corp Interim President & CEO, Director Common Shares 1.66M $5.44M $3.28 Feb 14, 2025 Direct
Arbutus Biopharma Corp Interim President & CEO, Director Stock Option (Right to Buy) 719K $1.39M $2.81 Feb 14, 2025 Direct

Insider Reports Filed by Michael J. McElhaugh

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ABUS Arbutus Biopharma Corp Feb 14, 2025 2 $0 4 Feb 19, 2025 Interim President & CEO, Director
ABUS Arbutus Biopharma Corp Feb 4, 2025 1 -$78.1K 4 Feb 5, 2025 Interim President & CEO, Director
ABUS Arbutus Biopharma Corp Feb 1, 2024 3 -$23.5K 4 Feb 5, 2024 Interim President & CEO, Director
ABUS Arbutus Biopharma Corp Feb 1, 2023 2 $0 4 Feb 3, 2023 Chief Business Officer
ABUS Arbutus Biopharma Corp Jan 20, 2022 1 $916K 4 Jan 20, 2022 Chief Business Officer